Contamac Revenue and Competitors

Saffron Walden, UK

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Contamac's estimated annual revenue is currently $24.3M per year.(i)
  • Contamac's estimated revenue per employee is $270,000

Employee Data

  • Contamac has 90 Employees.(i)
  • Contamac grew their employee count by 14% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M5233%N/AN/A
#2
$33.2M12321%N/AN/A
#3
$21.9M81-39%N/AN/A
#4
$37.3M1385%N/AN/A
#5
$25.1M933%N/AN/A
#6
$6.9M32-22%N/AN/A
#7
$210.6M62428%N/AN/A
#8
$69.2M2339%N/AN/A
#9
$23.2M866%N/AN/A
#10
$28.6M106-1%N/AN/A
Add Company

Contamac is a leader in the development of specialist polymers and a major global provider of biocompatible materials for implantable and medical applications to the ophthalmic industry. From its modern laboratory complex in Saffron Walden, England, Contamac manufactures a range of technically advanced materials providing a platform for eye correction on a global basis. We hope you find the information you are looking for. If you have any further questions please feel free to contact us directly and we will be delighted to help.

keywords:N/A

N/A

Total Funding

90

Number of Employees

$24.3M

Revenue (est)

14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Contamac News

2022-04-19 - Contact Lenses Market: Future Forecast Indicates Impressive ...

Contamac U.S. Inc. Hoya Corporation; Essilor International S.A.; Medennium; Johnson & Johnson Vision Care Inc. Request To Get Discount on this...

2022-04-17 - Colored contact lenses Market Revenue, competitive ...

... Inc., Surgical Vision, Inc., Carl Zeiss AG, Ciba Vision, Contamac, Essilor International, Hoya Corporation, Hydrogel Vision Corporation,...

2022-04-17 - Contact Lenses Market Research Analysis, Size, Share ...

Contamac Eagle Optics Essilor International SA Hoya Corp Hydrogel Vision Medennium STAAR Surgical Company SynergEyes...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$24.4M111-10%N/A
#2
$43.2M1876%N/A
#3
$67.5M1903%N/A